Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 22,747 | 10,713 | 6,542 | 14,791 | 14,327 |
| Gross Profit | 22,747 | 10,713 | 6,542 | 14,791 | 14,327 |
| Operating Expenses | 21,282 | 20,430 | 19,041 | 19,547 | 17,333 |
| Operating Income | 1,465 | -9,717 | -12,499 | -4,756 | -3,006 |
| Interest Expense | 1,886 | 2,630 | 2,034 | 2,242 | 2,240 |
| Other Income | 4,522 | 4,477 | 6,542 | 6,455 | 7,138 |
| Pre-tax Income | 4,101 | -7,870 | -7,991 | -543 | 1,892 |
| Income Tax | 32 | 15 | N/A | 16 | 11 |
| Net Income Continuous | 4,069 | -7,885 | -7,991 | -559 | 1,881 |
| Net Income | $4,069 | $-7,885 | $-7,991 | $-559 | $1,881 |
| EPS Basic Total Ops | 0.05 | -0.08 | -0.09 | -0.01 | 0.02 |
| EPS Basic Continuous Ops | 0.05 | -0.09 | -0.09 | -0.01 | 0.02 |
| EPS Diluted Total Ops | 0.05 | -0.08 | -0.09 | -0.01 | 0.02 |
| EPS Diluted Continuous Ops | 0.05 | -0.09 | -0.09 | -0.01 | 0.02 |
| EBITDA(a) | $3,068 | $-8,066 | $-10,887 | $-3,269 | $-1,594 |